Assoc. Prof. Jennie Clarke

Assoc. Prof. Jennie Clarke

Jennie T. Clarke, MD has specialized expertise in caring for patients with rheumatologic skin disease, such as lupus erythematosus and dermatomyositis, and other complex inflammatory dermatologic diseases in both children and adults. She also has a specialized interest in treating the skin conditions that occur commonly in patients with inflammatory bowel disease. In addition, she enjoys caring for general dermatology patients in her clinics. Dr. Clarke is also committed to the education of dermatology residents, and she is the supervising dermatologist of the resident dermatology continuity clinic at the University Hospital.

Associate Professor (Clinical)

University of Utah Department of Dermatology

Prof. Celia Moss

Prof. Celia Moss

Celia Moss is a Consultant Dermatologist at Birmingham Children's Hospital (BCH) and Honorary Professor of Paediatric Dermatology at the University of Birmingham. She trained in Medicine at Oxford University and University College Hospital, London, and in Dermatology in Newcastle-upon-Tyne. Previous national appointments include Chair of the British Society for Paediatric Dermatology, Chair of the UK NHS Clinical Reference Group for Specialised Dermatology, Convenor for Dermatology at the Royal College of Paediatrics and Child Health and Council Member of the Royal Society of Medicine Dermatology Section. She is a member of the advisory boards of several dermatology journals and patient support groups. She lectures, advises and publishes widely on genetic and paediatric dermatology, and has contributed chapters to the major UK and US textbooks. She was awarded the Sir Archibald Gray Medal and an OBE in 2016. Now semi-retired, she and her husband travel frequently, supporting colleagues overseas, particularly in India.
Prof. Neil Shear

Prof. Neil Shear

Professor Shear is Head of Dermatology at Sunnybrook Health Sciences Centre at the University of Toronto. His primary academic research is in Drug Safety, including basic mechanisms that lead to increased risk for drug-induced harm. His practice is considered advanced medical dermatology. Diseases of focus are atopic dermatitis, psoriasis, auto-immune blistering disease, drug-induced diseases, hidradenitis suppurativa, cutaneous lymphomas and auto-immune skin disease. Shear’s training is in Engineering Science (University of Toronto), Medicine (McMaster), Internal Medicine (FRCPC), Dermatology (FRCPC) and Clinical Pharmacology (Hospital for Sick Children, Toronto). Past positions include President of the Canadian Society of Clinical Pharmacology, President of the Canadian Professors of Dermatology, President of the Canadian Dermatology Foundation and Director of Dermatology at University of Toronto. He has been an honoured visiting professor over 50 times, made an honourary member of the Société Française de Dermatologie (2017) and the Scottish Dermatological Society, recipient of the Lifetime Achievement Award of the Ontario Medical Association, and many teaching awards (including the coveted Silver Shovel Award in undergraduate Medicine, University of Toronto). Dr. Shear has been an author of over 60 text book chapters and over 400 peer-reviewed publications. And he has had the pleasure of mentoring 40 postgraduate fellows from Canada and abroad; as well as a large number of dermatologists and clinical pharmacologists in Canada. Shear is the editor of Litt’s Drug Eruption Reference Manual (2019) and co-editor of Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends (2018).
Prof. Fenella Wojnarowska

Prof. Fenella Wojnarowska

I was educated at Somerville College, Oxford and St Mary’s Hospital Medical School, London and appointed clinical dermatology consultant at Oxford. Soon involved in clinical and scientific research I became Professor of Dermatology in 1999, one of the very few women Oxford clinical professors. My clinical and research interests were the autoimmune blistering diseases and women’s health including vulval disease, pregnancy dermatoses and their treatment. I was President of the British Society for the Study of Vulval Disease and the European Women’s Dermatologic Society and on the executive of the European Academy of Dermatology and Venereolgy. I was awarded a Platinum Award for Clinical Excellence by the Department of Health (<400 in total). I was Maria Duran Lecturer in 2006 for the International Dermatology Society. In 2009 I was awarded the Parkes-Weber Medal by the Royal College of Physicians, a Certificate of Appreciation by the International League of Dermatological Societies and received the ISSVD Presidential Recognition Award. Since retirement from I have been lead clinician for the BLISTER Trial published in the Lancet in 2017, and have particpated in Cochrane reviews and guidelines. In retirement I have focussed on Outreach, helping pupils from Cornwall, an impoversished and disadvantaged area, to go to Oxbridge, Medical School and high ranking universities. This involves mentoring, one of the favourite aspects of my career.

MSc, DM, FRCP
Professor Emeritus, University of Oxford
Prof. John McGrath

Prof. John McGrath

John McGrath is the academic head of St John’s Institute of Dermatology in London where he also runs the Genetic Skin Disease Group. He holds the Mary Dunhill Chair in Cutaneous Medicine at King’s College London and is Honorary Consultant Dermatologist to the Guy’s and St Thomas’ National Health Service Foundation Trust. He has lead roles in delivering experimental medicine and precision medicine within the Biomedical Research Centre at Guy’s Hospital and in organising several national phenotyping and genotyping of rare disease initiatives in the UK. His research focuses on the molecular characterization of inherited skin diseases and the development of novel treatments for rare skin diseases.
Dr. Paul Salmon

Dr. Paul Salmon

Dr Salmon is an academic Dermatologic Surgeon, he has over 60 papers published in the Peer-Reviewed Literature, skin cancer and reconstruction. As recognition of his international standing, last year he was awarded Honorary Fellowship in the Australasian College of Dermatology. For the last 20 years he has been a Chair or co-chair at the world congress of dermatology meetings on topics of skin cancer, Mohs surgery and reconstruction. He has been a guest presenter on reconstruction of the nose at the American College of Mohs Surgery meeting on several occasions, this is a singular honour especially for a non-American and cements his status as a globally recognized master of facial reconstruction. He continues to teach reconstruction through his Post-Doctoral Fellowship in Mohs and Cosmetic Surgery in New Zealand.

BHB MBChB FRACP Hon FACD FACMS FNZDSI